Javascript must be enabled to continue!
Stability Assessment through HPTLC for Concurrent Assessment of Azelnidipine and Telmisartan in Mass and Integrated Tablet Drug Formulation
View through CrossRef
This study aims to estimate the stability assessment through HPTLC for the concurrent assessment of (±)3-(1-diphenylmethylazetidin-3-yl)5-isopropyl-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate (Azelnidipine) and 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl] phenyl]benzoic acid (Telmisartan) in combined tablet formulation, a new HPTLC approach devised and validated that is simple, quick, precise, selective, and accurate stability suggesting. The adsorbent phase used is previously coated with a silica pack on TLC aluminum plates with 60F-254 using Chloroform: Ethyl acetate (5:5 v/v) of a total of 10 ml as the mobile phase. Both Azelnidipine (Rf 0.70) and Telmisartan (Rf 0.17), at 254 nm, densitometric scanning was performed in the reflectance absorptivity mode. In the linearity range of 1-6 μg/ml for Azelnidipine and 5-30 μg/ml for Telmisartan, the calibration graph demonstrated satisfactory linearity with r2 = 0.9967 and 0.9966, respectively. Azelnidipine and Telmisartan percentage assays were discovered to be 98.87 and 100.17. The percent RSD for intraday AZL and TLM experiments was 0.0184 and 0.0068. The percent RSD for AZL and TLM interday trials was discovered as 0.0126 and 0.0068. The LOD for AZL and TLM was discovered as 910 ng/mark and 4570 ng/mark. AZL and TLM were discovered to have LOQs of 2763 ng/mark and 13850 ng/mark, respectively. According to the ICH guidelines, drugs were exposed to acidic, basic, oxidative, photo, and heat-activated degradation. The medication degrades in acidic, basic, oxidative and heat environments but not in light or neutral environments (water). This procedure can be used to efficiently isolate the drug substance from its degradation products and this is used to indicate strength and stability.. KEYWORDS :Azelnidipine, Telmisartan, HPTLC, UV-visible spectroscopy, Validation, Stability studies.
Connect Journals
Title: Stability Assessment through HPTLC for Concurrent Assessment of Azelnidipine and Telmisartan in Mass and Integrated Tablet Drug Formulation
Description:
This study aims to estimate the stability assessment through HPTLC for the concurrent assessment of (±)3-(1-diphenylmethylazetidin-3-yl)5-isopropyl-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate (Azelnidipine) and 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl] phenyl]benzoic acid (Telmisartan) in combined tablet formulation, a new HPTLC approach devised and validated that is simple, quick, precise, selective, and accurate stability suggesting.
The adsorbent phase used is previously coated with a silica pack on TLC aluminum plates with 60F-254 using Chloroform: Ethyl acetate (5:5 v/v) of a total of 10 ml as the mobile phase.
Both Azelnidipine (Rf 0.
70) and Telmisartan (Rf 0.
17), at 254 nm, densitometric scanning was performed in the reflectance absorptivity mode.
In the linearity range of 1-6 μg/ml for Azelnidipine and 5-30 μg/ml for Telmisartan, the calibration graph demonstrated satisfactory linearity with r2 = 0.
9967 and 0.
9966, respectively.
Azelnidipine and Telmisartan percentage assays were discovered to be 98.
87 and 100.
17.
The percent RSD for intraday AZL and TLM experiments was 0.
0184 and 0.
0068.
The percent RSD for AZL and TLM interday trials was discovered as 0.
0126 and 0.
0068.
The LOD for AZL and TLM was discovered as 910 ng/mark and 4570 ng/mark.
AZL and TLM were discovered to have LOQs of 2763 ng/mark and 13850 ng/mark, respectively.
According to the ICH guidelines, drugs were exposed to acidic, basic, oxidative, photo, and heat-activated degradation.
The medication degrades in acidic, basic, oxidative and heat environments but not in light or neutral environments (water).
This procedure can be used to efficiently isolate the drug substance from its degradation products and this is used to indicate strength and stability.
KEYWORDS :Azelnidipine, Telmisartan, HPTLC, UV-visible spectroscopy, Validation, Stability studies.
Related Results
Designing, Critical Characterization, and Analytical RP-HPLC Method Development for Simultaneous Quantifications of Azelnidipine and Telmisartan Cocrystal
Designing, Critical Characterization, and Analytical RP-HPLC Method Development for Simultaneous Quantifications of Azelnidipine and Telmisartan Cocrystal
Introduction:
Azelnidipine and telmisartan are hypertensive medicines that belong to the BCS class II category and have low solubility and high permeability.
Cr...
Effects Of angiotensin II and Telmisartan on transient outward potassium and L-type calcium currents in Sprague–Dawley rat atrial myocytes
Effects Of angiotensin II and Telmisartan on transient outward potassium and L-type calcium currents in Sprague–Dawley rat atrial myocytes
Objective
To explore possible electrophysiological mechanisms of single atrial myocyte by evaluating the effects of angiotensinII (AngII) and telmisartan on trans...
Development and validation of spectroscopic simultaneous equation method for simultaneous estimation of Azelnidipine and Valsartan in synthetic mixture
Development and validation of spectroscopic simultaneous equation method for simultaneous estimation of Azelnidipine and Valsartan in synthetic mixture
A simple, specific, accurate and precise spectrophotometric method was developed and validated for simultaneous estimation of Azelnidipine and Valsartan in Synthetic Mixture. The w...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
Background:
Pancreatic ductal adenocarcinoma (PDAC) is the most devastating of all cancers with an extremely poor prognosis. It has few effective and reliable therapeut...
Chemical Fingerprints of Medicinal Plants - HPTLC Profiling
Chemical Fingerprints of Medicinal Plants - HPTLC Profiling
Chemical Fingerprints of Medicinal Plant- HPTLC Profiling gives an overview of the use of high-performance thin-layer chromatography (HPTLC) for profiling medicinal herbs. Starting...
Comparative Study of Olmesartan versus Telmisartan, in Patient with Stage I Hypertension
Comparative Study of Olmesartan versus Telmisartan, in Patient with Stage I Hypertension
Background: Hypertension is one of the most common diseases in the world. It is defined as sustained increase in blood pressure ≥ 140/90 mmHg. The risk of both microvascular & ...
Design, development and in vivo pharmacokinetic of telmisartan loaded oral disintegration tablets
Design, development and in vivo pharmacokinetic of telmisartan loaded oral disintegration tablets
Orodispersible Tablets (ODT) is a novel tableting technology which is formulated, and it overcomes the difficulties of other multi compressed tablets. Telmisartan has a bioavailabi...

